Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

The Lancet Gastroenterology & Hepatology - Tập 4 Số 7 - Trang 529-537 - 2019
Stuart A. Taylor1, Susan Mallett2, Sandy Beare3, Gauraang Bhatnagar4, Dominic Blunt5, Peter Boavida6, John Bridgewater7, Caroline S. Clarke8, Marian Duggan3, Steve Ellis9, Rob Glynne‐Jones10, Vicky Goh11, Ashley M. Groves12, Ayshea Hameeduddin9, Sam M. Janes13,14, Edward W. Johnston1, Dow‐Mu Koh15, Anne Miles16, Stephen Morris17, Alison J. Morton1, Neal Navani13,14, John O’Donohue18, Alfred Oliver1, Anwar R. Padhani19, Helen Pardoe20, Uday Patel21, Shonit Punwani1, Laura Quinn2, Hameed Rafiee22, Krystyna Reczko3, Andrea Rockall23,24, Khawaja Shahabuddin9, Harbir Sidhu1, Jonathan Teague3, Mohamed A. Thaha25,26, Matthew Train27, Katherine van Ree5, Sanjaya Wijeyekoon20, Steve Halligan1, Ruth Evans, Simon Ball, Revanth Jannapureddy, Tina Mills‐Baldock, Kishor Barhate, Zoltán Nagy, Sherif Raouf, Akosa Aboagye, Girija Anand, Rommel Butawan, Elizabeth Hadley, Adesewa Onajobi, Kathryn Tarver, Tanjil Nawaz, Catherine Norman, Nathalie Rich, Sidra Tulmuntaha, Shafi Ahmed, Louise Lim, Fiona McKirdy, Jenna Couture, Shahanara Ferdous, Payal Julka, Ali M. Somily, Terry O’Shaughnessy, William Ricketts, Marie Jackson, Clive Kay, Andy Lowe, Janet McGowan, Amjad Mohammed, Jon Robinson, Lara Curry, Sasithar Maheswaran, Subramanian Ramesh, Pippa Riddle, Shaki Balogun, Yvonne Campbell, Nelesh Jeyadevan, Aji Kavidasan, Imogen Locke, Tuck-Kay Loke, Ibiyemi Olaleye, Clare E. Collins, Elizabeth Green, Colm Prendergast, Thida Win, Amy Davis, Lyn Blakeway, Nicholas Gourtsoyiannis, Adrian Green, Christian Kelly‐Morland, Sahar Naaseri, Davide Prezzi, David Snell, Dorothee Boisfer, Keyury Desai, Balinder Hans, Sophia Hans, Eleni Ntala, Adnam Alam, Stephen Burke, Angshu Bhowmik, Nishat Bharwani, Gule Hanid, Lesley Honeyfield, Tina Stoycheva, Nicola H. Strickland, Farid Bazari, Helen Beedham, Jane De Los, Reyes Lauigan, Priya Limbu, Nicola Lucas, Sally O'Connor, Anita Rhodes, Laletha Agoramoorthy, Martha Handousa, Abel Jalloh, Stefania Stegner, Shanna Wilson, David G. Birch, Suzanne Chukundah, Priscilla Phiri, Rajaventhan Srirajaskanthan, Eleni Karapanagiotou, Daniel Smith, Ferrial Syeed, Chloe van Someren, Rudi Borgstein, Jamila Roehrig, David Chao, Lorraine Hurl, Andrew Gogbashian, André Nunes, Ian Simcock, James Stirling, Richard Beable, Maureen Furneaux, Nicola Gibbons, Antony Higginson, Howard Curtis, Kitrick Perry, Anita Amadi, Heather Hughes, Prital Patel, Gary Atkin, Colin Elton, Stephen E. Karp, Lisa Woodrow, Dominic Yu, Sajid Khan, Alistair Rienhardt, Pooja Datt, Rajapandian Ilangovan, Ian Jenkins, Saba Mahmud, Teresa Light, Joanne Kellaway, Ann O’Callaghan, William Partridge, Amelia Daniel, Ugo I. Ekeowa, Michael Long, Peter Russell, Erica Scurr, Veronica A. Morgan, Nina Tunariu, Elizabeth Chang, Laura Hughes, Ellice Marwood, Katie Prior, Meena Reddi, Kara Sargus, Abby Sharp, Greg Shaw, Elizabeth Isaac, Adoracion Jayme, Jagadish Kalasthry, Wivijin Piga, Farzana Rahman, Shraddha Weir, Aileen Austria, James Crosbie, Alec Engledow, Jonathan McCullogh, Austen Obichere, Kai-Keen Shiu, Christopher Wanstall, Celia Simeon, A Smith, Andrew Bateman, David J. Breen, Liane Davis, Chris Everitt, Alice Johnson, Paul Nichols, Beth Shepherd, Kayleigh Gilbert, Azmina Verjee, Michelle Saull, Jonathan J. Wilson, Rashidat Adeniba, Veronica Conteh, S.J. Howling, Sara Lock
1Centre for Medical Imaging, University College London, London, UK
2Institute of Applied Health Research, NIHR Birmingham Biomedical Research Centre, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
3Cancer Research UK & UCL Cancer Trials Centre, University College London, London, UK
4Frimley Park Hospital, Frimley, UK
5Imaging Department, Imperial College Healthcare NHS Trust, London, UK
6Department of Radiology, Homerton Hospital, London, UK
7UCL Cancer Institute, London, UK
8Research Department of Primary Care and Population Health, University College London, London, UK
9Department of Radiology, Barts Health NHS Trust, London, UK
10Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, UK
11Department of Cancer Imaging, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK
12Institute of Nuclear Medicine, University College London, London, UK
13Department of Thoracic Medicine, University College London Hospitals, UK
14Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK
15Department of Radiology, Royal Marsden Hospital, Sutton, Surrey UK
16Department of Psychological Sciences, Birkbeck, University of London, London, UK
17Department of Applied Health Research, University College London, London, UK
18Department of Gastroenterology, Lewisham Hospital, London, UK
19Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, UK
20Department of Surgery, Homerton Hospital, London, UK
21Intestinal Imaging Centre, St Mark's Hospital, LNWUH NHS Trust, Harrow, UK
22Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK
23Department of Cancer and Surgery, Imperial College London, London, UK
24Department of Radiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK
25Blizard Institute, National Bowel Research Centre, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
26Department of Surgery, Barts Health NHS Trust, The Royal London Hospital, London, UK
27Department of Radiology, Royal Free London NHS Foundation Trust, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Buyse, 2007, Progression-free survival is a surrogate for survival in advanced colorectal cancer, J Clin Oncol, 25, 5218, 10.1200/JCO.2007.11.8836

Mody, 2018, Clinical trials and progress in metastatic colon cancer, Surg Oncol Clin N Am, 27, 349, 10.1016/j.soc.2017.11.008

Shah, 2012, Radiation-induced cancer: a modern view, Br J Radiol, 85, e1166, 10.1259/bjr/25026140

Brocken, 2012, The faster the better? A systematic review on distress in the diagnostic phase of suspected cancer, and the influence of rapid diagnostic pathways, Psychooncology, 21, 1, 10.1002/pon.1929

Xu, 2013, Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis, Ann Oncol, 24, 96, 10.1093/annonc/mds234

Duo, 2013, Comparison of FDG PET/CT and gadolinium-enhanced MRI for the detection of bone metastases in patients with cancer: a meta-analysis, Clin Nucl Med, 38, 343, 10.1097/RLU.0b013e3182817af3

Li, 2014, Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a meta-analysis, Eur J Radiol, 83, 338, 10.1016/j.ejrad.2013.11.017

Liu, 2011, Fluorine-18 deoxyglucose positron emission tomography, magnetic resonance imaging and bone scintigraphy for the diagnosis of bone metastases in patients with lung cancer: which one is the best? A meta-analysis, Clin Oncol (R Coll Radiol), 23, 350, 10.1016/j.clon.2010.10.002

Wu, 2011, Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis, J Magn Reson Imaging, 34, 128, 10.1002/jmri.22608

Yang, 2011, Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy, Eur Radiol, 21, 2604, 10.1007/s00330-011-2221-4

Qu, 2012, A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer, Eur J Radiol, 81, 1007, 10.1016/j.ejrad.2011.01.126

Wu, 2013, Comparison of whole-body MRI and skeletal scintigraphy for detection of bone metastatic tumors: a meta-analysis, Surg Oncol, 22, 261, 10.1016/j.suronc.2013.10.004

Smets, 2018, Whole-body magnetic resonance imaging for detection of skeletal metastases in children and young people with primary solid tumors - systematic review, Pediatr Radiol, 48, 241, 10.1007/s00247-017-4013-8

Peerlings, 2016, The diagnostic value of MR imaging in determining the lymph node status of patients with non-small cell lung cancer: a meta-analysis, Radiology, 281, 86, 10.1148/radiol.2016151631

Shen, 2016, Performance of DWI in the nodal characterization and assessment of lung cancer: a meta-analysis, AJR Am J Roentgenol, 206, 283, 10.2214/AJR.15.15032

Wu, 2012, Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?, J Surg Res, 178, 304, 10.1016/j.jss.2012.03.074

Squillaci, 2008, Staging of colon cancer: whole-body MRI vs. whole-body PET-CT—initial clinical experience, Abdom Imaging, 33, 676, 10.1007/s00261-007-9347-5

Taylor, 2017, Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L), BMC Cancer, 17, 299, 10.1186/s12885-017-3281-x

Ferrante di Ruffano, 2012, Assessing the value of diagnostic tests: a framework for designing and evaluating trials, BMJ, 344, e686, 10.1136/bmj.e686

Taylor, 2019, Diagnostic accuracy of whole-body magnetic resonance imaging versus standard imaging pathways for metastatic disease in newly diagnosed non-small cell lung cancer: the prospective Streamline L trial, Lancet Respir Med, 10.1016/S2213-2600(19)30090-6

2010

Ohno, 2008, Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT, Radiology, 248, 643, 10.1148/radiol.2482072039

Rutjes, 2007, Evaluation of diagnostic tests when there is no gold standard. A review of methods, Health Technol Assess, 11, 50, 10.3310/hta11500

Evans, 2018, Perceived patient burden and acceptability of whole body MRI for staging lung and colorectal cancer; comparison with standard staging investigations, Br J Radiol, 91, 20170731, 10.1259/bjr.20170731

Evans, 2017, Patient experience and perceived acceptability of whole-body magnetic resonance imaging for staging colorectal and lung cancer compared with current staging scans: a qualitative study, BMJ Open, 7, e016391, 10.1136/bmjopen-2017-016391

Miles, 2019, Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment, Eur Radiol, 10.1007/s00330-019-06153-4

Alonzo, 2002, Sample size calculations for comparative studies of medical tests for detecting presence of disease, Stat Med, 21, 835, 10.1002/sim.1058

Newcombe, 1998, Improved confidence intervals for the difference between binomial proportions based on paired data, Stat Med, 17, 2635, 10.1002/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C

Niekel, 2010, Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment, Radiology, 257, 674, 10.1148/radiol.10100729

Hunter, 2016, Local staging and assessment of colon cancer with 1.5-T magnetic resonance imaging, Br J Radiol, 10.1259/bjr.20160257

Kubo, 2019, Vendor free basics of radiation dose reduction techniques for CT, Eur J Radiol, 110, 14, 10.1016/j.ejrad.2018.11.002

Olchowy, 2017, The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity—a systematic review, PLoS One, 12, e0171704, 10.1371/journal.pone.0171704